2 mg tirzepatide Mounjaro (tirzepatide) for the Treatment of Type Diabetes, USA Hair loss with GLP-1 drugs

Aim for at least eight glasses of water daily

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are now considered the first choice of injectable therapy for many people with T2D, with several members of the class having proven cardiovascular efficacy 3

Medication optimization strategies include following the FDA-approved titration schedule, which allows gradual adaptation to increasing doses

If treatment began at the full maintenance dose, many patients would experience severe nausea or vomiting

Seek urgent care for persistent severe abdominal pain, signs of severe hypoglycemia, or signs of dehydration and reduced urine output

Patients who have experienced issues with standard B12 supplementation sometimes prefer methylcobalamin-based formulations